Recent news on Relenza

Biota to Acquire CSIRO Relenza Royalty  -  May 3, 2007
PharmaLive.com (press release),A further payment will be triggered should future sales of Relenza meet an agreed target value. Specific terms of the agreement were not disclosed.

Japan investigates more flu drugs for inducing abnormal behaviour  -  May 15, 2007
CBC News,The drugs under review are zanamivir - sold by GlaxoSmithKline as Relenza - and amantadine, which have been linked to a total of 16 reports of abnormal

Japan investigates more flu drugs for inducing abnormal behaviour  -  May 15, 2007
Canada.com,The drugs under review are Relenza and Amantadine, which have been linked to a total of 16 reports of abnormal behaviour, Kyodo News agency said.

Japan Investigates Possible Link  -  May 15, 2007
Wall Street JournalThe drugs under review, GlaxoSmithKline PLC's Relenza and Novartis AG's Amantadine, have been linked to a total of 16 reports of abnormal behavior,

Drugs can be high-risk bet  -  May 5, 2007
Melbourne Herald Sun,Melbourne-based Biota Holdings is expecting a windfall from third-quarter royalties for the company's anti-flu drug Relenza -- up from $7.3 million for the

Japan to check more flu drugs for side effects  -  May 16, 2007
NewsweekDoctors investigating Tamiflu also found 16 cases of patients showing side effects after taking Relenza, an inhaled drug made by GlaxoSmithKline,

Strange behavior linked to 2 more flu drugs  -  May 15, 2007
Asahi Shimbun,Zanamivir is sold under the brand name Relenza, while Amantadine is marketed as Symmetrel. These and other cases of possible side effects were reported

Demand boosts Biota  -  Apr 26, 2007
Melbourne Herald Sun,GROWING demand for the anti-flu drug Relenza caused an 8.6 per cent spike yesterday in Biota Holdings shares, the single biggest gain by the stock in 12

Flu Treatments Under Investigation  -  May 16, 2007
WLNS,Japanese health officials looking into reports of possible side effects from the drugs Relenza and Amantadine. The popular drug Tamiflu is already under

Japan Investigates More Flu Drugs  -  May 15, 2007
WVVA TV,Now Japan's Health Ministry is looking into possible side effects from two other drugs, Relenza and Amantadine. Sixteen cases are under investigation.

Japan investigates more flu drugs  -  May 15, 2007
WIFR,Now Japan's Health Ministry is looking into possible side effects from two other drugs, Relenza and Amantadine (uh-MAN'-tuh-deen).

Japan investigates more flu drugs  -  May 14, 2007
KGAN,Now Japan's Health Ministry is looking into possible side effects from two other drugs, Relenza and Amantadine . Sixteen cases are under investigation.

Avian influenza (bird flu)  -  May 8, 2007
Health24.com,The newer flu drugs Tamiflu and Relenza appear to be effective weapons in fighting the disease – though it is feared that supplies could run out quickly in

Bumper profits continue to roll in for Australian banks  -  Apr 26, 2007
ABC Online,Biota says royalties from its flu drug, Relenza, have doubled in the third quarter to $16-million. That sent the company's share price up 8 per cent.

A tissue, a tissue, we all fall down  -  May 18, 2007
Brisbane Times,There are two prescription-only drugs - zanamivir (brand name Relenza) and oseltamivir (brand name Tamiflu) - that can reduce the length of the flu by

Ron Forster: Liberal spin could cost your common sense  -  May 16, 2007
Catoosa County News,As to preparedness for a potential pandemic flu outbreak, the governor recommended $15 million for Tamiflu and Relenza drugs to help those most at risk

Miracle drug could treat bird, human flu  -  May 14, 2007
Independent Online,It is time to find new treatments," Chui said. Relenza, made by GlaxoSmithKline is an inhaled drug regarded as capable of treating both bird and human flu.

Asia to test injectable drug to fight bird,human flu  -  May 14, 2007
ReutersRelenza, made by GlaxoSmithKline (GSK.L: Quote, Profile, Research(GSK.N: Quote, Profile, Research, is an inhaled drug regarded as capable of treating both

Asia to test injectable drug to fight bird,human flu  -  May 14, 2007
Reuters AlertNet,It is time to find new treatments," Chui said. Relenza, made by GlaxoSmithKline , is an inhaled drug regarded as capable of treating both bird and human flu.

Experiments at Australian particle accelerator  -  May 1, 2007
Manufacturing Talk,They are: Protein crystallography: Crucial for drug design, for example development of the flu drug Relenza; Powder diffraction: Plays a key role in

New Report Illuminates Ampligen(R)'s Unique Mechanism of Action  -  Apr 30, 2007
PipelineReview.com (press release),...of various serious human diseases as well as enhancing traditional antivirals such as Tamiflu(R) and Relenza(R). The experimental therapeutic Ampligen(R) is

Flu money's denial elicits warnings  -  Apr 27, 2007
Palm Beach Post,The coalition includes: the drug makers supplying Tamiflu and Relenza to the US Department of Health and Human Services, Roche and Glaxo Smith Klein;

Australian Stocks Climb, Led by BHP, Rio Tinto on China Demand  -  Apr 26, 2007
Bloomberg...to A$1.76, its highest in a year, after the company said royalties from GlaxoSmithKline Plc's flu drug Relenza more than doubled in the third quarter.

Biota announces A$16m quarterly royalties from Relenza antiviral  -  26 Apr 2007
PharmaLive.com (press release),Biota developed the first-in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza.

Demand boosts Biota  -  26 Apr 2007
Melbourne Herald Sun,GROWING demand for the anti-flu drug Relenza caused an 8.6 per cent spike yesterday in Biota Holdings shares, the single biggest gain by the stock in 12

Bumper profits continue to roll in for Australian banks  -  26 Apr 2007
ABC Online,Biota says royalties from its flu drug, Relenza, have doubled in the third quarter to $16-million. That sent the company's share price up 8 per cent.

In Brief  -  26 Apr 2007
Nature.com (subscription),Influenza B viruses are becoming resistant to Relenza and Tamiflu, two commonly used antiviral drugs, according to a Japanese review of strains isolated

Roche ready to scale back Tamiflu  -  26 Apr 2007
France24,It faces competition from the drug Relenza (zanamivir) by the British pharmaceutical giant GlaxoSmithKline. Both are used for flu prevention and treatment

Australian Stocks Climb, Led by BHP, Rio Tinto on China Demand  -  26 Apr 2007
Bloomberg...to A$1.76, its highest in a year, after the company said royalties from GlaxoSmithKline Plc's flu drug Relenza more than doubled in the third quarter.

Biota rips into GSK over lack of support for Relenza  -  Mar 30, 2007
Pharma Times (subscription),The lawsuit states that Relenza was first in a new class of antiviral flu drugs, and was "not known to have the resistance and side-effect issues"

GSK tackled over Relenza ‘exit strategy’  -  Mar 29, 2007
Financial Times,GlaxoSmithKline, the UK-based pharmaceutical company, failed to adequately promote the anti-flu drug Relenza and wrote off its development while long

Prime Time Pushers  -  Apr 19, 2007
Mother Jones,One example is the ongoing controversy over the GlaxoSK drug Relenza. Approved in 1999, Relenza is an inhalable powder designed to treat common flu symptoms

Feathers fly over flu drugs  -  Apr 4, 2007
Stuff.co.nz,LEGAL FLAPS: Its creators say Relenza is more effective against bird flu and other flu virses than tamiflu, but it has failed in the market.

Anti-Flu Drugs Losing Punch  -  Apr 18, 2007
ABC NewsApril 3, 2007 — Tamiflu and Relenza, two anti-viral drugs commonly used to treat influenza, may be losing their effectiveness as the flu virus adapts,

Biota Says New Evidence Details GSK's Comprehensive Failures to ...  -  Mar 29, 2007
PR Newswire (press release),Relenza is one of only two specific anti-influenza drugs recommended by the World Health Organization for global stockpiling to protect against pandemic

World war flu  -  Mar 30, 2007
The Age,Zanamivir, later to be marketed under the trade name Relenza, created a wave of excitement around the globe after its discovery in 1989.

GSK gave up on flu drug, suit says  -  Mar 28, 2007
News & Observer,But recent evidence has shown that Relenza, the drug made by GSK, causes fewer side effects and might be more effective than its competitor, Tamiflu.

Bird flu drug stymied  -  Mar 29, 2007
Melbourne Herald Sun,MELBOURNE biotech Biota claims its business partner concealed production cuts to its Relenza flu drug, meaning it could not be used to combat bird flu.

Bigger claim likely in flu case  -  Mar 29, 2007
The Australian,Relenza, the world's first broad-spectrum anti-flu drug, was launched in 1999, capturing almost half of the global market for flu medication within a year.

Influenza B viruses become resistant to Tamiflu  -  Apr 3, 2007
Food Consumer,Variants of viruses that cause influenza B were found to have become resistant to two common influenza drugs known as Tamiflu and Relenza, according to a

Study: flu virus mutants resist 2 popular drugs  -  Apr 3, 2007
Xinhua,Both antiviral drugs Tamiflu, manufactured by Roche and Relenza, manufactured by GlaxoSmithKline, are neuraminidase inhibitors, which have been effective

Biotech alleges bird flu cover-up  -  Mar 29, 2007
Advertiser Adelaide,AUSTRALIAN biotechnology company Biota claims its Relenza flu drug could not be used to combat an outbreak of bird flu in the Netherlands because its giant

Drug firms gear up to fight bird flu  -  Apr 15, 2007
Times of India,Recently, Cipla has developed a generic version of Relenza, 'Virenza' inhalation capsules which can be used for the treatment of influenza,

Japanese Study finds new Drug Resistant Flu  -  Apr 4, 2007
The Money Times,Type B flu viruses, a less common strain of flu, can mutate to develop resistance to two of the main antiviral drugs Tamiflu and Relenza prescribed to treat

Some Flu Viruses Resist Drugs  -  Apr 3, 2007
WebMDApril 3, 2007 -- Some flu viruses appear to resist the antiviral flu drugs Tamiflu and Relenza, report Japanese researchers. They included Shuji Hatakeyama,

Rare Flu Virus Shows Signs  -  Apr 4, 2007
Wall Street Journal (subscription),Signs of resistance to the drugs Tamiflu and Relenza turned up among a few patients who had type B influenza, normally a milder flu causing smaller

Biota fires a new salvo at drug giant  -  Mar 29, 2007
The Age,Biota, which licensed its flu drug Relenza to GSK in 1990, has accused the multinational of a breach of its contract to use its "best endeavours" to develop

New flu virus is Tamiflu-resistant: study  -  Apr 3, 2007
Turkish Press,They published the results of their study on the medications known by their trade names Tamiflu and Relenza in the US Journal of the American Medical

‘New flu strains resisting drugs’  -  Apr 7, 2007
The News - International,The Japanese researchers studied the effectiveness of Tamiflu and Relenza during an outbreak of a flu caused by a virus of the type B strain in the winter

Glaxo Profit Was Little Changed on Lower Drug Sales (Update7)  -  Apr 25, 2007
BloombergGlaxo's capacity for producing the antiviral drug Relenza has increased five-fold in the last two years as governments and the World Health Organization

Researchers find virus resistant to antiviral drugs in flu patients  -  Apr 3, 2007
London Free Press,TORONTO -- There is new and unwelcome evidence that flu viruses can evolve to develop resistance to the antiviral drugs Tamiflu and Relenza and that those

Researchers find viruses resistant to antiviral drugs in Japanese ...  -  Apr 3, 2007
Canada.com,TORONTO (CP) - There is new and unwelcome evidence that flu viruses can evolve to develop resistance to the antiviral drugs Tamiflu and Relenza and that

Resistant to flu drugs,type-B strain causes alarm  -  Apr 4, 2007
Orlando Sentinel,Signs of resistance to the drugs Tamiflu and Relenza turned up among a few patients who had type-B influenza, normally a milder flu causing smaller

Tamiflu resistance found in Japanese flu viruses  -  Apr 3, 2007
CBC Ottawa,There is new and unwelcome evidence that flu viruses can develop partial resistance to the antiviral drugs Tamiflu and Relenza and spread from person to

GlaxoSmithKline: Results Announcement for the First Quarter 2007  -  Apr 25, 2007
PharmaLive.com (press release),Sales of Relenza, GSK’s anti-viral for influenza, were £92 million reflecting demand from governments to stockpile it for use in the event of a pandemic.

Study finds drug-resistant flu virus in Japan  -  Apr 4, 2007
China Post,The research involved Tamiflu, an antiviral drug made by Roche and Gilead Sciences, and Relenza, made by GlaxoSmithKline and Biota Holdings,

Study Finds Some Resistance to Flu Drugs  -  Apr 3, 2007
Atlanta Journal Constitution (subscription),The two drugs, zanamivir (Relenza) and oseltamivir (Tamiflu), have been effective against the flu and are widely used, particularly in Japan, according to

Study finds drug-resistant flu virus in Japan  -  Apr 3, 2007
Reuters AlertNet,The research involved Tamiflu, an antiviral drug made by Roche and Gilead Sciences , and Relenza, made by GlaxoSmithKline and Biota Holdings , and known

Drug Resistant Flu Strains Appear to be Emerging  -  Apr 4, 2007
News Locale,Japanese researchers report influenza B strains of viruses are now marginally resistant to Tamiflu and Relenza in that country.

Drug resistant strains found for influenza B  -  Apr 4, 2007
Earthtimes.orgThe researchers examined Tamiflu and Relenza in the study. The former made by Roche happens to be the drug of choice in H5N1 type of influenza as well as

Lotto fight sustained sick man, son says  -  Apr 4, 2007
ChronicleHerald.ca,TORONTO (CP) — There is new and unwelcome evidence that flu viruses can evolve to develop resistance to the antiviral drugs Tamiflu and Relenza and that

Flu Showing Signs Of Resistance To Antivirals  -  Apr 4, 2007
Medical News Today,Antiviral drugs like oseltamivir (Tamiflu) and zanamivir (Relenza) are from a group known as neuraminidase inhibitors. They halt the spread of the flu virus

Neuraminidase Resistance Seen in Influenza B  -  Apr 3, 2007
MedPage Today,Influenza B resistance to oseltamivir (Tamiflu) and zanamivir (Relenza) also appears to be transmitted within communities and families, reported Shuji

Biota’s HRV Drug successfully completes Phase I Clinical Trial  -  27 Mar 2007
PharmaLive.com (press release),Biota developed the first-inclass neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline (GSK) as Relenza. Relenza is currently being

Chip goes to Chile but can't make the mine  -  27 Mar 2007
The Age,This Friday another biotech, Melbourne-based Biota, lodges its updated claim against GSK in a long-running dispute over the influenza antiviral drug Relenza

Flu pandemic to hurt state economies  -  Mar 22, 2007
Arizona Republic,Nations are preparing for a pandemic by stockpiling drugs such as Roche Holding AG's Tamiflu, GlaxoSmithKline Plc's Relenza, and vaccines against H5N1 made

Doctors who have treated bird flu cases meet to share treatment info  -  Mar 18, 2007
Canada.com,...(GlaxoSmithKline, which makes Relenza, has shelved plans to test an intravenous form of the drug in the United States, but is in discussions with a

Probing past and future materials with neutrons  -  Mar 15, 2007
NOVA Science In The NewsIt's the basis of rational drug design and has been used in the creation of the first anti-flu drug Relenza and in the HIV protease inhibitors.

Shionogi Buys Japanese Rights to BioCryst's Flu Drug (Update3)  -  Mar 6, 2007
BloombergPeramivir is in the same class of drugs as Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza. The World Health Organization and an international

BioCryst in Japanese bird flu deal  -  Mar 6, 2007
CNNMoney.comBioCryst signs license agreement with Japanese biotech for experimental bird flu drug; could rival Tamiflu, Relenza. By Aaron Smith, CNNMoney.com staff

New Studies Indicate GSK's Pre-Pandemic Influenza Vaccine Can ...  -  Mar 23, 2007
Drug Newswire (press release),January 2007: GSK begins supplying its antiviral, Relenza(R) (zanamivir for inhalation), to the US government and begins working with private-sector

Boost for Biota research productivity  -  Mar 1, 2007
EurekAlert (press release),Zanamivir is licensed to GlaxoSmithKline and marketed as Relenza™. Relenza is used to treat seasonal influenza and is currently being stockpiled by various

BioCryst signs flu drug deal with Japan's Shionogi  -  Mar 6, 2007
Pharma Times (subscription),...neuraminidase inhibitor to hit the market and will be competing against Roche's Tamiflu (oseltamivir) and GlaxoSmithKline's inhaled Relenza (zanamivir).

New Studies Indicate GSK's Pre-pandemic Influenza Vaccine Can ...  -  Mar 12, 2007
Medical News Today (press release),January 2007: GSK begins supplying its antiviral, Relenza® (zanamivir for inhalation), to the USgovernment and begins working with private-sector businesses

Ottawa to spend $2-million to research drugs that fight flu  -  Mar 24, 2007
Globe and Mail,The existing flu drugs are zanamivir (Relenza) and oseltamivir (Tamiflu) and two older off-patent drugs called amantadine and rimantadine (which is not sold

New Studies Indicate GSK's Pre-Pandemic Influenza Vaccine Can ...  -  Mar 5, 2007
PR Newswire (press release),Relenza and Daronrix are registered trade marks of the GlaxoSmithKline group of companies Inquiries US Media inquiries: Nancy Pekarek (215) 751 7709 Mary

Glaxo's Vaccine Booster May Be Added to Sanofi Shots (Update2)  -  Mar 13, 2007
BloombergIn addition to vaccine, the US and other governments are stockpiling antiviral drugs such as Roche Holding AG's Tamiflu pills and Glaxo's inhaled Relenza.

Florida Ignores Federal Help For Flu  -  Mar 23, 2007
The Ledger,It's not at all clear whether antiviral medicines like Tamiflu or Relenza would be effective in minimizing the symptoms of a new, vigorous influenza strain,

Toyama Chemical begins US trials of bird flu drug  -  Mar 12, 2007
Canada.com,The current class of drugs used to treat bird flu are called neuraminidase inhibitors which include Tamiflu, GlaxoSmithKline's Relenza and the drug

Toyama Chemical Begins US Trials of Bird Flu Drug  -  Mar 12, 2007
Reuters.uk,N: Quote, Profile , Research) Relenza and drug candidate peramivir being developed by BioCryst Pharmaceuticals Inc. (BCRX.O: Quote, Profile , Research).

Roche applies to create child-sized Tamiflu  -  Mar 9, 2007
CNNMoney.comGovernments and companies around the world are stockpiling Tamiflu and a rival drug, GlaxoSmithKline's (down $0.11 to $55.52, Charts) Relenza,

Roche Applies to Make Child-Sized Tamiflu  -  Mar 9, 2007
Reuters.uk,...and a rival drug, GlaxoSmithKline's (GSK.L: Quote, Profile , Research) (GSK.N: Quote, Profile , Research) Relenza, in case a pandemic does break out.

Roche applies to make child-sized Tamiflu  -  Mar 9, 2007
ReutersTamiflu and a rival drug, GlaxoSmithKline's (GSK.L: Quote, Profile, Research) (GSK.N: Quote, Profile, Research) Relenza, in case a pandemic does break out.

Inhaler to deliver powerful anti-flu drugs  -  Mar 7, 2007
DrugResearcher.com,Biota licensed the drug to GlaxoSmithKline (GSK) in 1990 and it was launched worldwide in 1999 under the brand name Relenza. The drug is delivered using a

Officials consider flu drug funding  -  Mar 5, 2007
Kansas City Star,The federal government is willing to pick up 25 percent of the cost of 600477 five-day treatments of Tamiflu and Relenza.

Kuwait culls 25000 birds in anti-bird flu campaign  -  Mar 5, 2007
Kuwait News Agency,He explained that Tamiflu and Relenza had proven effective in protecting humans against the virus, but called on the public to forego the hobby of bird

Two high-level Oregon policy makers war over the state's ...  -  Feb 28, 2007
Willamette Week,20, Allan declined a federal offer to sell the state 360930 subsidized treatment courses of Tamiflu and Relenza, two antiviral drugs often described as

US experts to weigh Sanofi bird flu vaccine  -  Feb 26, 2007
Scientific AmericanUnlike Roche Holding AG's and Gilead Sciences Inc's Tamiflu and Glaxo's Relenza, two drugs that can treat H5N1 and regular seasonal flu after infection,

Flu pandemic would create ethical dilemmas  -  Feb 26, 2007
The State,In 1999, the Food and Drug Administration approved two new drugs to fight flu: Relenza (zanamivir) and Tamiflu (oseltamivir). Two other drugs were approved

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional